<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37118836</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2051-5960</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>28</Day></PubDate></JournalIssue><Title>Acta neuropathologica communications</Title><ISOAbbreviation>Acta Neuropathol Commun</ISOAbbreviation></Journal><ArticleTitle>Microglial CD68 and L-ferritin upregulation in response to phosphorylated-TDP-43 pathology in the amyotrophic lateral sclerosis brain.</ArticleTitle><Pagination><StartPage>69</StartPage><MedlinePgn>69</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">69</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40478-023-01561-6</ELocationID><Abstract><AbstractText>Microglia, the innate immune cells of the brain, are activated by damage or disease. In mouse models of amyotrophic lateral sclerosis (ALS), microglia shift from neurotrophic to neurotoxic states with disease progression. It remains unclear how human microglia change relative to the TAR DNA-binding protein 43 (TDP-43) aggregation that occurs in 97% of ALS cases. Here we examine spatial relationships between microglial activation and TDP-43 pathology in brain tissue from people with ALS and from a TDP-43-driven ALS mouse model. Post-mortem human brain tissue from the Neurological Foundation Human Brain Bank was obtained from 10 control and 10 ALS cases in parallel with brain tissue from a bigenic NEFH-tTA/tetO-hTDP-43&#x2206;NLS (rNLS) mouse model of ALS at disease onset, early disease, and late disease stages. The spatiotemporal relationship between microglial activation and ALS pathology was determined by investigating microglial functional marker expression in brain regions with low and high TDP-43 burden at end-stage human disease: hippocampus and motor cortex, respectively. Sections were immunohistochemically labelled with a two-round multiplexed antibody panel against; microglial functional markers (L-ferritin, HLA-DR, CD74, CD68, and Iba1), a neuronal marker, an astrocyte marker, and pathological phosphorylated TDP-43 (pTDP-43). Single-cell levels of microglial functional markers were quantified using custom analysis pipelines and mapped to anatomical regions and ALS pathology. We identified a significant increase in microglial Iba1 and CD68 expression in the human ALS motor cortex, with microglial CD68 being significantly correlated with pTDP-43 pathology load. We also identified two subpopulations of microglia enriched in the ALS motor cortex that were defined by high L-ferritin expression. A similar pattern of microglial changes was observed in the rNLS mouse, with an increase first in CD68 and then in L-ferritin expression, with both occurring only after pTDP-43 inclusions were detectable. Our data strongly suggest that microglia are phagocytic at early-stage ALS but transition to a dysfunctional state at end-stage disease, and that these functional states are driven by pTDP-43 aggregation. Overall, these findings enhance our understanding of microglial phenotypes and function in ALS.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Swanson</LastName><ForeName>Molly E V</ForeName><Initials>MEV</Initials><AffiliationInfo><Affiliation>School of Biological Sciences, University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Brain Research, University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mrkela</LastName><ForeName>Miran</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Biological Sciences, University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Brain Research, University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Helen C</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Centre for Brain Research, University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Maize C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Centre for Brain Research, University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology and Clinical Pharmacology, University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Clinton</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anatomical Pathology, Pathology and Laboratory Medicine, Auckland City Hospital, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curtis</LastName><ForeName>Maurice A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Centre for Brain Research, University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faull</LastName><ForeName>Richard L M</ForeName><Initials>RLM</Initials><AffiliationInfo><Affiliation>Centre for Brain Research, University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anatomy and Medical Imaging, University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>Adam K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Queensland Brain Institute, University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scotter</LastName><ForeName>Emma L</ForeName><Initials>EL</Initials><Identifier Source="ORCID">0000-0003-4064-3599</Identifier><AffiliationInfo><Affiliation>School of Biological Sciences, University of Auckland, Auckland, New Zealand. emma.scotter@auckland.ac.nz.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Brain Research, University of Auckland, Auckland, New Zealand. emma.scotter@auckland.ac.nz.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Neuropathol Commun</MedlineTA><NlmUniqueID>101610673</NlmUniqueID><ISSNLinking>2051-5960</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9013-31-4</RegistryNumber><NameOfSubstance UI="D001052">Apoferritins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C578077">TDP-43 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001052" MajorTopicYN="N">Apoferritins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">CD68</Keyword><Keyword MajorTopicYN="N">L-ferritin</Keyword><Keyword MajorTopicYN="N">Microglia</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword></KeywordList><CoiStatement>The authors report no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>29</Day><Hour>19</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>29</Day><Hour>0</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37118836</ArticleId><ArticleId IdType="pmc">PMC10142752</ArticleId><ArticleId IdType="doi">10.1186/s40478-023-01561-6</ArticleId><ArticleId IdType="pii">10.1186/s40478-023-01561-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mandrioli J, Faglioni P, Nichelli P, Sola P. Amyotrophic lateral sclerosis: prognostic indicators of survival. Amyotroph Lateral Scler. 2006;4:217&#x2013;226. doi: 10.1080/17482960600947648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960600947648</ArticleId><ArticleId IdType="pubmed">17127559</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter EL, Chen H-J, Shaw CE. TDP-43 proteinopathy and ALS: insights into disease mechanisms and therapeutic targets. Neurotherapeutics. 2015;2:352&#x2013;363. doi: 10.1007/s13311-015-0338-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-015-0338-x</ArticleId><ArticleId IdType="pmc">PMC4404432</ArticleId><ArticleId IdType="pubmed">25652699</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Calvo A, Chio A, Colville S, Ellis CM, et al. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol. 2014;11:1108&#x2013;1113. doi: 10.1016/S1474-4422(14)70219-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70219-4</ArticleId><ArticleId IdType="pmc">PMC4197338</ArticleId><ArticleId IdType="pubmed">25300936</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;5796:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Kettenmann H, Hanisch U-K, Noda M, Verkhratsky A. Physiology of microglia. Physiol Rev. 2011;2:461&#x2013;553. doi: 10.1152/physrev.00011.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00011.2010</ArticleId><ArticleId IdType="pubmed">21527731</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao B, Zhao W, Beers DR, Henkel JS, Appel SH. Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Exp Neurol. 2012;1:147&#x2013;152. doi: 10.1016/j.expneurol.2012.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2012.06.011</ArticleId><ArticleId IdType="pmc">PMC4126417</ArticleId><ArticleId IdType="pubmed">22735487</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry VH, Nicoll JAR, Holmes C. Microglia in neurodegenerative disease. Nat Rev Neurol. 2010;4:193&#x2013;201. doi: 10.1038/nrneurol.2010.17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2010.17</ArticleId><ArticleId IdType="pubmed">20234358</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Beers DR, Bell S, Wang J, Wen S, et al. TDP-43 activates microglia through NF-&#x3ba;B and NLRP3 inflammasome. Exp Neurol. 2015 doi: 10.1016/j.expneurol.2015.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.07.019</ArticleId><ArticleId IdType="pubmed">26222336</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey J, Venkatesh S, Hasan R, Herb JT, de Paiva LK, et al. Integrative transcriptomic analysis of the amyotrophic lateral sclerosis spinal cord implicates glial activation and suggests new risk genes. Nat Neurosci. 2023;1:150&#x2013;162. doi: 10.1038/s41593-022-01205-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-022-01205-3</ArticleId><ArticleId IdType="pubmed">36482247</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter M, Spiller KJ, Dominique MA, Xu H, Hunter FW, et al. Microglial transcriptome analysis in the rNLS8 mouse model of TDP-43 proteinopathy reveals discrete expression profiles associated with neurodegenerative progression and recovery. Acta Neuropathol Commun. 2021;1:1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8377972</ArticleId><ArticleId IdType="pubmed">34412701</ArticleId></ArticleIdList></Reference><Reference><Citation>Graber DJ, Hickey WF, Harris BT. Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis. J Neuroinflammation. 2010 doi: 10.1186/1742-2094-7-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-7-8</ArticleId><ArticleId IdType="pmc">PMC2825214</ArticleId><ArticleId IdType="pubmed">20109233</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamenkovi&#x107; S, Du&#x10d;i&#x107; T, Stamenkovi&#x107; V, Kranz A, Andjus PR. Imaging of glial cell morphology SOD1 distribution and elemental composition in the brainstem and hippocampus of the ALS hSOD1G93A rat. Neuroscience. 2017 doi: 10.1016/j.neuroscience.2017.05.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2017.05.041</ArticleId><ArticleId IdType="pubmed">28576725</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanagi T, Yuasa S, Nakamura Y, Suzuki E, Aoki M, et al. Appearance of phagocytic microglia adjacent to motoneurons in spinal cord tissue from a presymptomatic transgenic rat model of amyotrophic lateral sclerosis. J Neurosci Res. 2010;12:2736&#x2013;2746.</Citation><ArticleIdList><ArticleId IdType="pubmed">20648658</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerber YN, Sabourin JC, Rabano M, Vivanco MDM, Perrin FE. Early functional deficit and microglial disturbances in a mouse model of amyotrophic lateral sclerosis. PLoS ONE. 2012 doi: 10.1371/journal.pone.0036000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0036000</ArticleId><ArticleId IdType="pmc">PMC3338492</ArticleId><ArticleId IdType="pubmed">22558300</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohgomori T, Yamada J, Takeuchi H, Kadomatsu K, Jinno S. Comparative morphometric analysis of microglia in the spinal cord of SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis. Eur J Neurosci. 2016;10:1340&#x2013;1351. doi: 10.1111/ejn.13227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.13227</ArticleId><ArticleId IdType="pubmed">26946061</ArticleId></ArticleIdList></Reference><Reference><Citation>Schludi MH, Becker L, Garrett L, Gendron TF, Zhou Q, et al. Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron loss. Acta Neuropathol. 2017;2:241&#x2013;254. doi: 10.1007/s00401-017-1711-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1711-0</ArticleId><ArticleId IdType="pmc">PMC5508040</ArticleId><ArticleId IdType="pubmed">28409281</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller KJ, Restrepo CR, Khan T, Dominique MA, Fang TC, et al. Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat Neurosci. 2018;3:329&#x2013;340. doi: 10.1038/s41593-018-0083-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0083-7</ArticleId><ArticleId IdType="pmc">PMC5857237</ArticleId><ArticleId IdType="pubmed">29463850</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara JH, Gen&#xe7; B, Stanford MJ, Pytel P, Roos RP, et al. Evidence for an early innate immune response in the motor cortex of ALS. J Neuroinflammation. 2017;1:1&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5485686</ArticleId><ArticleId IdType="pubmed">28651542</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu IM, Morimoto ETA, Goodarzi H, Liao JT, O&#x2019;Keeffe S, et al. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 2013;2:385&#x2013;401. doi: 10.1016/j.celrep.2013.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.018</ArticleId><ArticleId IdType="pmc">PMC4272581</ArticleId><ArticleId IdType="pubmed">23850290</ArticleId></ArticleIdList></Reference><Reference><Citation>Funikov SY, Rezvykh AP, Mazin PV, Morozov AV, Maltsev AV, et al. FUS(1&#x2013;359) transgenic mice as a model of ALS: pathophysiological and molecular aspects of the proteinopathy. Neurogenetics. 2018;3:189&#x2013;204. doi: 10.1007/s10048-018-0553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-018-0553-9</ArticleId><ArticleId IdType="pubmed">29982879</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Zhao W, Liao B, Kano O, Wang J, et al. Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice. Brain Behav Immun. 2011;5:1025&#x2013;1035. doi: 10.1016/j.bbi.2010.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2010.12.008</ArticleId><ArticleId IdType="pmc">PMC3096756</ArticleId><ArticleId IdType="pubmed">21176785</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell JC, McGoldrick P, Vance C, Hortobagyi T, Sreedharan J, et al. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol. 2013;2:273&#x2013;288. doi: 10.1007/s00401-012-1043-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1043-z</ArticleId><ArticleId IdType="pmc">PMC3549237</ArticleId><ArticleId IdType="pubmed">22961620</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan JY, Jeong SY, van Gelderen P, Deng HX, Quezado MM, et al. Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: Correlating 7 tesla MRI and pathology. PLoS ONE. 2012 doi: 10.1371/journal.pone.0035241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035241</ArticleId><ArticleId IdType="pmc">PMC3328441</ArticleId><ArticleId IdType="pubmed">22529995</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan M, Scott C, Gamarallage MP, Lunn D, Carpenter K, et al. Quantitative patterns of motor cortex proteinopathy across ALS genotypes. Acta Neuropathol Commun. 2020;1:98. doi: 10.1186/s40478-020-00961-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-00961-2</ArticleId><ArticleId IdType="pmc">PMC7331195</ArticleId><ArticleId IdType="pubmed">32616036</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Venugopal S, Majid S, Ahn IS, Diamante G, et al. Single-cell RNA-seq analysis of the brainstem of mutant SOD1 mice reveals perturbed cell types and pathways of amyotrophic lateral sclerosis. Neurobiol Dis. 2020;141:104877. doi: 10.1016/j.nbd.2020.104877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104877</ArticleId><ArticleId IdType="pmc">PMC7519882</ArticleId><ArticleId IdType="pubmed">32360664</ArticleId></ArticleIdList></Reference><Reference><Citation>Dachet F, Liu J, Ravits J, Song F. Predicting disease specific spinal motor neurons and glia in sporadic ALS. Neurobiol Dis. 2019;130:104523. doi: 10.1016/j.nbd.2019.104523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104523</ArticleId><ArticleId IdType="pubmed">31276795</ArticleId></ArticleIdList></Reference><Reference><Citation>Dols-Icardo O, Montal V, Sirisi S, L&#xf3;pez-Pernas G, Cervera-Carles L, et al. Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflammation. 2020;5:e829. doi: 10.1212/NXI.0000000000000829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000829</ArticleId><ArticleId IdType="pmc">PMC7371375</ArticleId><ArticleId IdType="pubmed">32669313</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes KO, Sparks DL, Streit WJ. Microglial dystrophy in the aged and Alzheimer&#x2019;s disease brain is associated with ferritin immunoreactivity. Glia. 2008;10:1048&#x2013;1060. doi: 10.1002/glia.20678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20678</ArticleId><ArticleId IdType="pubmed">18442088</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson MEV, Murray HC, Ryan B, Faull RLM, Dragunow M, et al. Quantitative immunohistochemical analysis of myeloid cell marker expression in human cortex captures microglia heterogeneity with anatomical context. Sci Rep. 2020;1:11693. doi: 10.1038/s41598-020-68086-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-68086-z</ArticleId><ArticleId IdType="pmc">PMC7366669</ArticleId><ArticleId IdType="pubmed">32678124</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer PL, Itagaki S, McGeer EG. Expression of the histocompatibility glycoprotein HLA-DR in neurological disease. Acta Neuropathol. 1988;6:550&#x2013;557. doi: 10.1007/BF00689592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00689592</ArticleId><ArticleId IdType="pubmed">2974227</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez FO, Gordon S (2014) The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep March. 13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3944738</ArticleId><ArticleId IdType="pubmed">24669294</ArticleId></ArticleIdList></Reference><Reference><Citation>Melief J, Koning N, Schuurman KG, van de Garde MDB, Smolders J, et al. Phenotyping primary human microglia: tight regulation of LPS responsiveness. Glia. 2012;10:1506&#x2013;1517. doi: 10.1002/glia.22370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22370</ArticleId><ArticleId IdType="pubmed">22740309</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker DG, Lue L-FF. Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains. Alzheimers Res Ther. 2015;1:56. doi: 10.1186/s13195-015-0139-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-015-0139-9</ArticleId><ArticleId IdType="pmc">PMC4543480</ArticleId><ArticleId IdType="pubmed">26286145</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker-Herman S, Arie G, Medvedovsky H, Kerem A, Shachar I. CD74 is a member of the regulated intramembrane proteolysis-processed protein family. Mol Biol Cell. 2005;11:5061&#x2013;5069. doi: 10.1091/mbc.e05-04-0327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e05-04-0327</ArticleId><ArticleId IdType="pmc">PMC1266406</ArticleId><ArticleId IdType="pubmed">16107560</ArticleId></ArticleIdList></Reference><Reference><Citation>Zotova E, Bharambe V, Cheaveau M, Morgan W, Holmes C, et al. Inflammatory components in human Alzheimer&#x2019;s disease and after active amyloid-&#x3b2;42 immunization. Brain. 2013;9:2677&#x2013;2696. doi: 10.1093/brain/awt210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt210</ArticleId><ArticleId IdType="pubmed">23943781</ArticleId></ArticleIdList></Reference><Reference><Citation>Holness CL, Simmons DL. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood. 1993;6:1607&#x2013;1613. doi: 10.1182/blood.V81.6.1607.1607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V81.6.1607.1607</ArticleId><ArticleId IdType="pubmed">7680921</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohsawa K, Imai Y, Kanazawa H, Sasaki Y, Kohsaka S. Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia. J Cell Sci. 2000 doi: 10.1242/jcs.113.17.3073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.113.17.3073</ArticleId><ArticleId IdType="pubmed">10934045</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai Y, Ibata I, Ito D, Ohsawa K, Kohsaka S. A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun. 1996;3:855&#x2013;862. doi: 10.1006/bbrc.1996.1112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1996.1112</ArticleId><ArticleId IdType="pubmed">8713135</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, et al. Microglia-specific localisation of a novel calcium binding protein, Iba1. Mol Brain Res. 1998;1:1&#x2013;9. doi: 10.1016/S0169-328X(98)00040-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0169-328X(98)00040-0</ArticleId><ArticleId IdType="pubmed">9630473</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Libon DJ, Toledo JB, Xie SX, McCluskey L, et al. Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis. Acta Neuropathol. 2012;3:395&#x2013;407. doi: 10.1007/s00401-011-0932-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0932-x</ArticleId><ArticleId IdType="pmc">PMC3595560</ArticleId><ArticleId IdType="pubmed">22210083</ArticleId></ArticleIdList></Reference><Reference><Citation>Rifai OM, O&#x2019;Shaughnessy J, Dando OR, Munro AF, Sewell MDE, et al. (2023) Distinct neuroinflammatory signatures exist across genetic and sporadic ALS cohorts. bioRxiv (Preprint)</Citation></Reference><Reference><Citation>Brettschneider J, Toledo JB, van Deerlin VM, Elman L, McCluskey L, et al. Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis. PLoS ONE. 2012;6:13&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3375234</ArticleId><ArticleId IdType="pubmed">22720079</ArticleId></ArticleIdList></Reference><Reference><Citation>Rifai OM, Longden J, O&#x2019;Shaughnessy J, Sewell MDE, Pate J, et al. Random forest modelling demonstrates microglial and protein misfolding features to be key phenotypic markers in C9orf72-ALS. J Pathol. 2022;4:366&#x2013;381. doi: 10.1002/path.6008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.6008</ArticleId><ArticleId IdType="pmc">PMC9827842</ArticleId><ArticleId IdType="pubmed">36070099</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolicelli RC, Sierra A, Stevens B, Tremblay ME, Aguzzi A, et al. Microglia states and nomenclature: a field at its crossroads. Neuron. 2022;21:3458&#x2013;3483. doi: 10.1016/j.neuron.2022.10.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.020</ArticleId><ArticleId IdType="pmc">PMC9999291</ArticleId><ArticleId IdType="pubmed">36327895</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q, Mareljic N, Michaelsen M, Parhizkar S, Heindl S, et al. Active poly-GA vaccination prevents microglia activation and motor deficits in a C9orf72 mouse model. EMBO Mol Med. 2020;2:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7005532</ArticleId><ArticleId IdType="pubmed">31858749</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronica E, Baas F, Iyer A, ten Asbroek ALMA, Morello G, et al. Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex. Neurobiol Dis. 2015 doi: 10.1016/j.nbd.2014.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.12.002</ArticleId><ArticleId IdType="pubmed">25500340</ArticleId></ArticleIdList></Reference><Reference><Citation>Noristani HN, Sabourin JC, Gerber YN, Teigell M, Sommacal A, et al. Brca1 is expressed in human microglia and is dysregulated in human and animal model of ALS. Mol Neurodegener. 2015;1:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4521418</ArticleId><ArticleId IdType="pubmed">26227626</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, et al. A unique microglia type associated with restricting development of Alzheimer&#x2019;s disease. Cell. 2017;7:1276&#x2013;1290.e17. doi: 10.1016/j.cell.2017.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.05.018</ArticleId><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, del Tredici K, Toledo JB, Robinson JL, Irwin DJ, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol. 2013;1:20&#x2013;38. doi: 10.1002/ana.23937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AK, Spiller KJ, Ge G, Zheng A, Xu Y, et al. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol. 2015;5:643&#x2013;660. doi: 10.1007/s00401-015-1460-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1460-x</ArticleId><ArticleId IdType="pmc">PMC5127391</ArticleId><ArticleId IdType="pubmed">26197969</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldvogel HJ, Curtis MA, Baer K, Rees MI, Faull RLM. Immunohistochemical staining of post-mortem adult human brain sections. Nat Protoc. 2007;6:2719&#x2013;2732.</Citation><ArticleIdList><ArticleId IdType="pubmed">17406528</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright AL, Della Gatta PA, Le S, Berning BA, Mehta P, et al. Riluzole does not ameliorate disease caused by cytoplasmic TDP-43 in a mouse model of amyotrophic lateral sclerosis. Eur J Neurosci. 2021;6:6237&#x2013;6255. doi: 10.1111/ejn.15422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.15422</ArticleId><ArticleId IdType="pubmed">34390052</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray HC, Dieriks BV, Swanson MEV, Anekal PV, Turner C, et al. The unfolded protein response is activated in the olfactory system in Alzheimer&#x2019;s disease. Acta Neuropathol Commun. 2020;1:109. doi: 10.1186/s40478-020-00986-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-00986-7</ArticleId><ArticleId IdType="pmc">PMC7362534</ArticleId><ArticleId IdType="pubmed">32665027</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieriks BV, Dean JM, Aronica E, Waldvogel HJ, Faull RLM, et al. Differential fatty acid-binding protein expression in persistent radial glia in the human and sheep subventricular zone. Dev Neurosci. 2018;2:145&#x2013;161. doi: 10.1159/000487633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000487633</ArticleId><ArticleId IdType="pubmed">29680832</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray HC, Johnson K, Sedlock A, Highet B, Dieriks BV, et al. Lamina-specific immunohistochemical signatures in the olfactory bulb of healthy, Alzheimer&#x2019;s and Parkinson&#x2019;s disease patients. Commun Biol. 2022;1:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786934</ArticleId><ArticleId IdType="pubmed">35075270</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson MEV, Scotter EL, Murray HC, Turner C, Faull RLMM, et al. Identification of a dysfunctional microglial population in human Alzheimer&#x2019;s disease cortex using novel single-cell histology image analysis. Acta Neuropathol Commun. 2020;1:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7576851</ArticleId><ArticleId IdType="pubmed">33081847</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolf Z, Swanson MEV, Smyth LC, Mee EW, Schweder P, et al. Single-cell image analysis reveals a protective role for microglia in glioblastoma. Neurooncol Adv. 2021 doi: 10.1093/noajnl/vdab031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/noajnl/vdab031</ArticleId><ArticleId IdType="pmc">PMC8284623</ArticleId><ArticleId IdType="pubmed">34286275</ArticleId></ArticleIdList></Reference><Reference><Citation>Krijthe JH (2015) T-Distributed stochastic neighbor embedding using barnes-hut implementation. https://github.com/jkrijthe/Rtsne</Citation></Reference><Reference><Citation>van der Maaten L. Accelerating t-SNE using tree-based algorithms. J Mach Learn Res. 2015;15:3221&#x2013;3245.</Citation></Reference><Reference><Citation>Kobak D, Berens P. The art of using t-SNE for single-cell transcriptomics. Nat Commun. 2019 doi: 10.1038/s41467-019-13056-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13056-x</ArticleId><ArticleId IdType="pmc">PMC6882829</ArticleId><ArticleId IdType="pubmed">31780648</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao J, Spielmann M, Qiu X, Huang X, Ibrahim DM, et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature. 2019;7745:496&#x2013;502. doi: 10.1038/s41586-019-0969-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-0969-x</ArticleId><ArticleId IdType="pmc">PMC6434952</ArticleId><ArticleId IdType="pubmed">30787437</ArticleId></ArticleIdList></Reference><Reference><Citation>Belkina AC, Ciccolella CO, Anno R, Halpert R, Spidlen J, et al. Automated optimized parameters for T-distributed stochastic neighbor embedding improve visualization and analysis of large datasets. Nat Commun. 2019;1:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6882880</ArticleId><ArticleId IdType="pubmed">31780669</ArticleId></ArticleIdList></Reference><Reference><Citation>Beygelzimer A, Kakadet S, Langford J, Arya S, Mount D, et al. (2019) FNN: fast nearest neighbor search algorithms and applications. https://cran.r-project.org/web/packages/FNN/index.html</Citation></Reference><Reference><Citation>Csardi G, Nepusz T. The igraph software package for complex network research. InterJournal. 2006;1695(5):1&#x2013;9.</Citation></Reference><Reference><Citation>Streit WJ, Walter SA, Pennell NA. Reactive microgliosis. Prog Neurobiol. 1999;6:563&#x2013;581. doi: 10.1016/S0301-0082(98)00069-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0301-0082(98)00069-0</ArticleId><ArticleId IdType="pubmed">10221782</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie M, Liu YU, Zhao S, Zhang L, Bosco DB, et al. TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration. Nat Neurosci. 2022;1:26&#x2013;38. doi: 10.1038/s41593-021-00975-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00975-6</ArticleId><ArticleId IdType="pmc">PMC8741737</ArticleId><ArticleId IdType="pubmed">34916658</ArticleId></ArticleIdList></Reference><Reference><Citation>Svahn AJ, Don EK, Badrock AP, Cole NJ, Graeber MB, et al. Nucleo-cytoplasmic transport of TDP-43 studied in real time: impaired microglia function leads to axonal spreading of TDP-43 in degenerating motor neurons. Acta Neuropathol. 2018;3:445&#x2013;459. doi: 10.1007/s00401-018-1875-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1875-2</ArticleId><ArticleId IdType="pmc">PMC6096729</ArticleId><ArticleId IdType="pubmed">29943193</ArticleId></ArticleIdList></Reference><Reference><Citation>Streit WJ, Braak H, Xue QS, Bechmann I. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer&#x2019;s disease. Acta Neuropathol. 2009;4:475&#x2013;485. doi: 10.1007/s00401-009-0556-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0556-6</ArticleId><ArticleId IdType="pmc">PMC2737117</ArticleId><ArticleId IdType="pubmed">19513731</ArticleId></ArticleIdList></Reference><Reference><Citation>Streit WJ, Xue QS. Life and death of microglia. J Neuroimmune Pharmacol. 2009;4:371&#x2013;379. doi: 10.1007/s11481-009-9163-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-009-9163-5</ArticleId><ArticleId IdType="pubmed">19680817</ArticleId></ArticleIdList></Reference><Reference><Citation>Streit WJ, Xue Q-S, Tischer J, Bechmann I. Microglial pathology. Acta Neuropathol Commun. 2014;1:142. doi: 10.1186/s40478-014-0142-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-014-0142-6</ArticleId><ArticleId IdType="pmc">PMC4180960</ArticleId><ArticleId IdType="pubmed">25257319</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosher KI, Wyss-Coray T. Microglial dysfunction in brain aging and Alzheimer&#x2019;s disease. Biochem Pharmacol. 2014;4:594&#x2013;604. doi: 10.1016/j.bcp.2014.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2014.01.008</ArticleId><ArticleId IdType="pmc">PMC3972294</ArticleId><ArticleId IdType="pubmed">24445162</ArticleId></ArticleIdList></Reference><Reference><Citation>Quek H, Cun&#xed;-L&#xf3;pez C, Stewart R, Colletti T, Notaro A, et al. ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression. J Neuroinflammation. 2022;1:1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8887023</ArticleId><ArticleId IdType="pubmed">35227277</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>